New Vascepa Approval Opens Up Treatment to Millions
The high-dose fish oil product is being touted as the most significant event in cardiovascular prevention since statins, but the broad indication granted has left some unsure.
Related Articles
TG Takeover: Rapid-Fire Updates on Advances in sHTG and FCS
Join us for this live event.Hypertriglyceridemia is a causal contributor to atherosclerotic cardiovascular disease (ASCVD), and when triglyceride (TG) levels…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Severe Hypertriglyceridemia Education Hub
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
Severe Hypertriglyceridemia Education Hub
A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in…
Pulmonary Arterial Hypertension Fellows Forum: Key Insights on Diagnosis and Referral Practices
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening condition that imposes significant physical, emotional, and financial burdens on pat…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
TG Takeover: Rapid-Fire Updates on Advances in sHTG and FCS
Join us for this live event.Hypertriglyceridemia is a causal contributor to atherosclerotic cardiovascular disease (ASCVD), and when triglyceride (TG) levels…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…